UNICA IRIS Institutional Research Information System

LACHOWICZ, JOANNA IZABELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 153.722
NA - Nord America 8.364
AS - Asia 3.615
SA - Sud America 574
Continente sconosciuto - Info sul continente non disponibili 425
AF - Africa 104
OC - Oceania 15
Totale 166.819
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 150.776
US - Stati Uniti d'America 8.187
SG - Singapore 1.356
CN - Cina 1.175
NL - Olanda 1.086
SE - Svezia 551
BR - Brasile 439
UA - Ucraina 359
VN - Vietnam 307
FI - Finlandia 199
DE - Germania 194
GB - Regno Unito 191
FR - Francia 152
IN - India 108
HK - Hong Kong 105
CA - Canada 103
KR - Corea 78
BD - Bangladesh 75
SA - Arabia Saudita 70
MX - Messico 44
AR - Argentina 43
IQ - Iraq 42
TR - Turchia 42
ES - Italia 40
JP - Giappone 39
PK - Pakistan 36
RU - Federazione Russa 27
IR - Iran 25
ID - Indonesia 24
EC - Ecuador 22
PL - Polonia 22
AT - Austria 21
ZA - Sudafrica 21
EG - Egitto 20
CO - Colombia 18
IE - Irlanda 18
MA - Marocco 18
UZ - Uzbekistan 17
BE - Belgio 16
VE - Venezuela 15
AU - Australia 14
RO - Romania 13
TH - Thailandia 13
CL - Cile 12
AE - Emirati Arabi Uniti 11
KE - Kenya 11
TN - Tunisia 11
IL - Israele 10
MY - Malesia 10
PH - Filippine 10
GR - Grecia 9
JO - Giordania 9
LT - Lituania 9
CH - Svizzera 8
BO - Bolivia 7
JM - Giamaica 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
TW - Taiwan 6
UY - Uruguay 6
CI - Costa d'Avorio 5
NP - Nepal 5
PA - Panama 5
PE - Perù 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
DZ - Algeria 4
LB - Libano 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BH - Bahrain 3
KW - Kuwait 3
QA - Qatar 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
Totale 166.377
Salva come PNG Salva come JPEG
Città #
Cagliari 147.732
Uta 2.475
Amsterdam 1.064
Ashburn 1.040
Fairfield 709
Singapore 671
Woodbridge 489
Dallas 456
San Jose 447
Nyköping 367
Chandler 334
Houston 318
Boardman 313
Wilmington 270
Seattle 267
Ann Arbor 254
Cambridge 230
Beijing 217
Council Bluffs 186
Jacksonville 181
Los Angeles 176
Dearborn 164
Helsinki 136
Santa Clara 136
New York 124
The Dalles 116
Ho Chi Minh City 106
Hong Kong 91
Lauterbourg 91
Boston 79
Shanghai 77
Nanjing 70
Hefei 69
Seoul 66
Hanoi 65
Dong Ket 60
Escalaplano 58
San Diego 54
Buffalo 51
Orem 50
Redwood City 48
Chicago 42
Guangzhou 41
London 40
Milan 38
Sassari 34
São Paulo 34
Hangzhou 32
Rome 31
Nanchang 30
Frankfurt am Main 29
Tianjin 27
Atlanta 26
Phoenix 26
Mountain View 25
Tokyo 25
Toronto 25
Brooklyn 24
Columbus 23
Nuremberg 23
Redondo Beach 23
Shenyang 23
Chennai 22
Montreal 22
Munich 19
Changsha 18
Baghdad 17
Mumbai 17
Da Nang 16
Ottawa 16
Hebei 15
Jiaxing 14
Manchester 14
Norwalk 14
Pune 14
Rio de Janeiro 14
Tashkent 14
Washington 14
Brasília 13
Brussels 13
Dhaka 13
Mexico City 13
Shenzhen 13
Warsaw 13
Dublin 12
Jinan 12
Orange 12
Turku 12
Vienna 12
Zhengzhou 12
Nairobi 11
Salt Lake City 10
San Francisco 10
Stockholm 10
Belo Horizonte 9
Johannesburg 9
Pittsburgh 9
Amman 8
Denver 8
Falls Church 8
Totale 161.030
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.751
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.859
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.639
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.553
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.543
Multi analytical technique study of human bones from an archaeological discovery 3.440
Multiple Sclerosis and environmental factors. 3.300
Adsorption of Cu2+ and Zn2+ on SBA-15 mesoporous silica functionalized with triethylenetetramine chelating agent 3.267
Gold - Old drug with new potentials 3.229
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.963
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.802
Metal coordination of thymosin β4: Chemistry and possible implications 2.799
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.753
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.661
Thymosin b4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study 2.623
Looking at new ligands for chelation therapy 2.567
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.493
null 2.477
Depleted uranium and human health 2.472
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.445
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.416
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.306
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.261
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.235
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.217
Do anti-diabetic drugs act as copper ligands? 2.214
Toxicity of nanoparticles: etiology and mechanisms 2.158
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.077
Tungsten or wolfram: Friend or foe? 2.058
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.044
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.979
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.970
The meaning of aluminium exposure on human health and aluminium-related diseases 1.937
Kill or cure: Misuse of chelation therapy for human diseases 1.929
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.902
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.896
Silver coordination compounds: A new horizon in medicine 1.876
Improving Metal Adsorption on Triethylenetetramine (TETA) Functionalized SBA-15 Mesoporous Silica Using Potentiometry, EPR and ssNMR 1.868
Alarming use of chelation therapy 1.853
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.840
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.832
Chemical features of in use and in progress chelators for iron overload 1.831
The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides 1.830
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.827
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.806
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.800
State of art in chelating agents for the clinical treatment of metal poisoning 1.797
Noble metals in medicine: Latest advances 1.792
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.784
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.779
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.769
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.766
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.735
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.716
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.628
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.616
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.591
Toxicity of nanoparticles 1.388
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know 1.292
Warns against unapproved ‘chelation therapy’ 1.207
null 1.188
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.164
Zinc as a drug for Wilson’s disease, non-alcoholic liver disease and covid-19-related liver injury 1.120
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 1.116
Grafting of the 2,8-dithia-5-aza-2,6-pyridinophane macrocycle on SBA-15 mesoporous silica for the removal of Cu2+ and Cd2+ ions from aqueous solutions: synthesis, adsorption, and complex stability studies 1.078
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells 980
Nutritional iron deficiency: the role of oral iron supplementation 950
null 941
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis 929
Kojic acid derivatives as double face ligands for metal and phosphate ions. 915
Kojic Acid Derivatives as Iron (III) and Aluminium (III) Chelators 913
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 905
Metal complex formation and anticancer activity of cu(I) and cu(ii) complexes with metformin 879
Exploring cell surface markers and cell-cell interactions of human breast milk stem cells 873
Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexes 861
null 845
Manganese and cobalt binding in a multi-histidinic fragment 840
Kojic Acid derivate as a selective inhibitor of mitosis in colorectal and glioblastoma cancer cells 834
Metals and metal-nanoparticles in human pathologies: From exposure to therapy 822
Fluorescent squaramide ligands for cellular imaging and their encapsulation in cubosomes 743
Nickel Binding Sites in Histone Proteins: Spectroscopic and Structural Characterization 738
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease 726
Potentiometric, spectrophotometric and computer studies with aspergillic acid and its derivatives 705
Interaction between aspergillic acid and iron(III). A potentiometric, UV-Vis, 1H-NMR and quantum chemical study 583
Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium 569
Toward the renal vesicle: Ultrastructural investigation of the cap mesenchyme splitting process in the developing kidney 566
Cooking Particulate Matter: A Systematic Review on Nanoparticle Exposure in the Indoor Cooking Environment 557
Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators 542
Human breast milk cells are positive for the pioneer transcription factor ISL1 540
NMR as a “gold standard” method in drug design and discovery 504
Nuovi derivati dell’acido kojico come chelanti per il ferro(III). 484
What doesn't kill you makes you stronger: Future applications of amyloid aggregates in biomedicine 470
A pilot study of occupational exposure to ultrafine particles during 3D printing in research laboratories 466
You are what you eat: Application of Metabolomics Approaches to Advance Nutrition Research 363
Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin 357
The interaction of aluminum with catecholamine-based neurotransmitters: Can the formation of these species be considered a potential risk factor for neurodegenerative diseases? 353
In silico design of mimosine containing peptides as new efficient chelators of aluminum 353
Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways 302
Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations 268
Therapeutic Properties of Vanadium Complexes 239
Totale 166.039
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.773 0 731 398 535 609 618 475 271 544 755 913 924
2022/202310.333 794 1.170 1.265 886 852 1.178 597 948 686 632 785 540
2023/202411.762 588 468 435 622 1.149 1.846 1.925 1.130 521 796 1.088 1.194
2024/202524.614 5.936 6.383 3.084 2.268 1.316 1.548 1.680 155 337 1.264 312 331
2025/20267.187 498 353 799 529 438 507 1.361 648 690 805 383 176
2026/2027556 134 422 0 0 0 0 0 0 0 0 0 0
Totale 166.819